Researchers have compiled the most comprehensive collection of human intestinal bacteria to date, isolating over 100 bacterial species from healthy individuals for the first time.
Take a look at this month’s industry headlines including an FDA approval for a vaccine protecting against six diseases, positive clinical trial results for bacteraemia and dengue vaccines and new funding for CRSIPR-based antimicrobials.
Researchers from the Howard Hughes Medical Institute have developed a novel genetic tool for detecting fast and accurate measures of latent HIV.
Researchers from Newcastle University have reported the presence of antibiotic-resistant genes in one of the most remote, ‘unspoiled’ regions on Earth.
The UK government has published a 20-year vision and a 5-year national action plan for how the UK will contribute to controlling and containing antimicrobial resistance by 2040.
Researchers have identified a non-polio enterovirus – EV-D68 – as the potential cause of an outbreak of acute flaccid myelitis cases in Arizona.
New research has provided evidence that basophils might play an important role in the immune response to bacterial infections, preventing the development of sepsis.
A study published in the BMJ, involving more than 19 million patients, has concluded that 23.9% of antibiotic prescriptions given to outpatients in the US are inappropriate.
A first for clinical trials in the US as researchers from the University of California San Diego School of Medicine get US FDA approval to use intravenously-administered bacteriophage therapy in hopes of combatting resistant bacteria.